Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spain ups ante on joint procurement of new hepatitis C drugs

This article was originally published in Scrip

Executive Summary

Amid mounting pressure to provide access to the costly new hepatitis C drugs, the Spanish health ministry has confirmed it is pushing for progress on the joint procurement of such products with other EU member states. Companies will be paying close attention to how the situation unfolds as it could set the bar for which treatments come under the scope of a new agreement that allows member states to wield their combined purchasing power to get a better price for expensive new drugs.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts